JPRN-jRCTs031200124
Completed
未知
Study on the use of Convalescent plasma therapy as a COVID-19 treatment - Study on the use of Convalescent plasma therapy as a COVID-19 treatment
Saito Sho0 sites11 target enrollmentSeptember 17, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- COVID-19, Coronavirus disease
- Sponsor
- Saito Sho
- Enrollment
- 11
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The study was terminated; the analysis originally planned was not performed. The study was terminated in accordance with the recommendation of the Efficacy and Safety Evaluation Committee. However, this does not negate the assumption: "The rate of intubation in the existing treatment is assumed to be 25%, and this rate should be reduced by more than half (i.e., to 12% or less).
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Written consent obtained from the patient or his/her legal representative.
- •2\) COVID\-19 diagnosed by PCR, LAMP, etc. and was admitted.
- •3\) Patients who satisfy the following at admission: A) SpO2 \<\= 94% or B) require supplimental oxygen.
- •4\) 20 years or older at enrollment
Exclusion Criteria
- •1\) Pregnant or breastfeeding at enrollment
- •2\) Unable to conduct blood transfusion due to religious reasons
- •3\) Enrolled in other COVID\-19 intervension study
- •4\) Previously administered with COVID\-19 convalescent plasma
- •5\) Known allergy to blood products
- •6\) Deficiency of plasma protein, such as IgA
- •7\) Not appropriate to enroll determined by the PI for other reasons
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Prospective study for effectiveness of Etelcalcetide hydrochloride (Parsabiv) on patients treated with hemodialysispatients treated with hemodialysisJPRN-UMIN000032637Zenjinkai Shinyokohama Daiichi Clinic Division of Nephrology20
Completed
Not Applicable
A pilot study of heat immunotherapy using cationic magnetoliposome for advanced melanoma patients - combined therapy with topical imiquimod immunotherapymelanomaJPRN-UMIN000006414Department of Dermatology, Shinshu University School of Medicine5
Completed
Phase 2
A phase II clinical trial of Carbon-ion therapy for patients with bone and soft tissue sarcomas not suited for surgical resectioBone and soft tissue tumorJPRN-UMIN000021557Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
Completed
Not Applicable
Intra-retinal arterial fibrinolysisJPRN-jRCTs031180441Kadonosono Kazuaki3
Completed
Not Applicable
Investigation of Factors Affecting the Therapeutic Effectiveness of Mirror Therapy for Shoulder Pain : A Randomized Crossover Trialshoulder painJPRN-UMIN000052590Hayashi Hospital